Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | 指定難病告示番号 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 86 drugs (DrugBank) and 81 diseases |
ADRB1 1件: ADRB1 💬Adrenergic signaling in cardiomyocytes
|
Atenolol Atenolol 💬Adrenergic signaling in cardiomyocytes
| Atenolol | 167 1件: 167 💬1. Adrenergic signaling in cardiomyocytes
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 86 drugs (DrugBank) and 81 diseases |
ADRB1 1件: ADRB1 💬Adrenergic signaling in cardiomyocytes
|
Nebivolol Nebivolol 💬Adrenergic signaling in cardiomyocytes
| Nebivolol | 017 4件: 17, 85, 113, 167 💬2. Adrenergic signaling in cardiomyocytes
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 86 drugs (DrugBank) and 81 diseases |
ADRB1 1件: ADRB1 💬Adrenergic signaling in cardiomyocytes
|
Nebivolol hydrochloride Nebivolol hydrochloride 💬Adrenergic signaling in cardiomyocytes
| Nebivolol | 017 4件: 17, 85, 113, 167 💬2. Adrenergic signaling in cardiomyocytes
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 86 drugs (DrugBank) and 81 diseases |
ADRB1 2件: ADRB1, ADRB2 💬
|
Propranolol hydrochloride Propranolol hydrochloride 💬Adrenergic signaling in cardiomyocytes
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬4. Adrenergic signaling in cardiomyocytes
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 86 drugs (DrugBank) and 81 diseases |
ADRB1 2件: ADRB1, ADRB2 💬
|
Propranolol Propranolol 💬Adrenergic signaling in cardiomyocytes
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬4. Adrenergic signaling in cardiomyocytes
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 86 drugs (DrugBank) and 81 diseases |
AGTR1 1件: AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Irbesartan Irbesartan 💬Adrenergic signaling in cardiomyocytes
| Irbesartan | 057 6件: 57, 66, 167, 168, 222, 223 💬6. Adrenergic signaling in cardiomyocytes
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 86 drugs (DrugBank) and 81 diseases |
AGTR1 1件: AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan potassium Losartan potassium 💬Adrenergic signaling in cardiomyocytes
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬7. Adrenergic signaling in cardiomyocytes
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 86 drugs (DrugBank) and 81 diseases |
AGTR1 1件: AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Losartan Losartan 💬Adrenergic signaling in cardiomyocytes
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬7. Adrenergic signaling in cardiomyocytes
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 86 drugs (DrugBank) and 81 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬Adrenergic signaling in cardiomyocytes
|
Verapamil hydrochloride Verapamil hydrochloride 💬Adrenergic signaling in cardiomyocytes
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 86 drugs (DrugBank) and 81 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬Adrenergic signaling in cardiomyocytes
|
Verapamil Verapamil 💬Adrenergic signaling in cardiomyocytes
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 11 | AGE-RAGE signaling pathway in diabetic complications 💬 28 genes, 58 drugs (DrugBank) and 100 diseases |
AGTR1 1件: AGTR1 💬AGE-RAGE signaling pathway in diabetic complications
|
Irbesartan Irbesartan 💬AGE-RAGE signaling pathway in diabetic complications
| Irbesartan | 057 6件: 57, 66, 167, 168, 222, 223 💬11. AGE-RAGE signaling pathway in diabetic complications
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 12 | AGE-RAGE signaling pathway in diabetic complications 💬 28 genes, 58 drugs (DrugBank) and 100 diseases |
AGTR1 1件: AGTR1 💬AGE-RAGE signaling pathway in diabetic complications
|
Losartan potassium Losartan potassium 💬AGE-RAGE signaling pathway in diabetic complications
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬12. AGE-RAGE signaling pathway in diabetic complications
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 13 | AGE-RAGE signaling pathway in diabetic complications 💬 28 genes, 58 drugs (DrugBank) and 100 diseases |
AGTR1 1件: AGTR1 💬AGE-RAGE signaling pathway in diabetic complications
|
Losartan Losartan 💬AGE-RAGE signaling pathway in diabetic complications
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬12. AGE-RAGE signaling pathway in diabetic complications
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 14 | Aldosterone synthesis and secretion 💬 20 genes, 43 drugs (DrugBank) and 63 diseases |
AGTR1 1件: AGTR1 💬Aldosterone synthesis and secretion
|
Irbesartan Irbesartan 💬Aldosterone synthesis and secretion
| Irbesartan | 057 6件: 57, 66, 167, 168, 222, 223 💬14. Aldosterone synthesis and secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 15 | Aldosterone synthesis and secretion 💬 20 genes, 43 drugs (DrugBank) and 63 diseases |
AGTR1 1件: AGTR1 💬Aldosterone synthesis and secretion
|
Losartan potassium Losartan potassium 💬Aldosterone synthesis and secretion
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬15. Aldosterone synthesis and secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 16 | Aldosterone synthesis and secretion 💬 20 genes, 43 drugs (DrugBank) and 63 diseases |
AGTR1 1件: AGTR1 💬Aldosterone synthesis and secretion
|
Losartan Losartan 💬Aldosterone synthesis and secretion
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬15. Aldosterone synthesis and secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 17 | Aldosterone synthesis and secretion 💬 20 genes, 43 drugs (DrugBank) and 63 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬Aldosterone synthesis and secretion
|
Verapamil hydrochloride Verapamil hydrochloride 💬Aldosterone synthesis and secretion
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 18 | Aldosterone synthesis and secretion 💬 20 genes, 43 drugs (DrugBank) and 63 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬Aldosterone synthesis and secretion
|
Verapamil Verapamil 💬Aldosterone synthesis and secretion
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 19 | Alzheimer disease 💬 59 genes, 136 drugs (DrugBank) and 139 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬Alzheimer disease
|
Verapamil hydrochloride Verapamil hydrochloride 💬Alzheimer disease
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 20 | Alzheimer disease 💬 59 genes, 136 drugs (DrugBank) and 139 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬Alzheimer disease
|
Verapamil Verapamil 💬Alzheimer disease
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 21 | Amphetamine addiction 💬 25 genes, 58 drugs (DrugBank) and 92 diseases |
CACNA1C 2件: CACNA1C, CACNA1D 💬
|
Verapamil hydrochloride Verapamil hydrochloride 💬Amphetamine addiction
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 22 | Amphetamine addiction 💬 25 genes, 58 drugs (DrugBank) and 92 diseases |
CACNA1C 2件: CACNA1C, CACNA1D 💬
|
Verapamil Verapamil 💬Amphetamine addiction
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 23 | Apelin signaling pathway 💬 18 genes, 37 drugs (DrugBank) and 81 diseases |
AGTR1 1件: AGTR1 💬Apelin signaling pathway
|
Irbesartan Irbesartan 💬Apelin signaling pathway
| Irbesartan | 057 6件: 57, 66, 167, 168, 222, 223 💬23. Apelin signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 24 | Apelin signaling pathway 💬 18 genes, 37 drugs (DrugBank) and 81 diseases |
AGTR1 1件: AGTR1 💬Apelin signaling pathway
|
Losartan potassium Losartan potassium 💬Apelin signaling pathway
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬24. Apelin signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 25 | Apelin signaling pathway 💬 18 genes, 37 drugs (DrugBank) and 81 diseases |
AGTR1 1件: AGTR1 💬Apelin signaling pathway
|
Losartan Losartan 💬Apelin signaling pathway
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬24. Apelin signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 26 | Arrhythmogenic right ventricular cardiomyopathy 💬 14 genes, 30 drugs (DrugBank) and 33 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬Arrhythmogenic right ventricular cardiomyopathy
|
Verapamil hydrochloride Verapamil hydrochloride 💬Arrhythmogenic right ventricular cardiomyopathy
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 27 | Arrhythmogenic right ventricular cardiomyopathy 💬 14 genes, 30 drugs (DrugBank) and 33 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬Arrhythmogenic right ventricular cardiomyopathy
|
Verapamil Verapamil 💬Arrhythmogenic right ventricular cardiomyopathy
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 28 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
ADRB1 1件: ADRB1 💬Calcium signaling pathway
|
Atenolol Atenolol 💬Calcium signaling pathway
| Atenolol | 167 1件: 167 💬28. Calcium signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 29 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
ADRB1 1件: ADRB1 💬Calcium signaling pathway
|
Nebivolol Nebivolol 💬Calcium signaling pathway
| Nebivolol | 017 4件: 17, 85, 113, 167 💬29. Calcium signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 30 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
ADRB1 1件: ADRB1 💬Calcium signaling pathway
|
Nebivolol hydrochloride Nebivolol hydrochloride 💬Calcium signaling pathway
| Nebivolol | 017 4件: 17, 85, 113, 167 💬29. Calcium signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 31 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
ADRB1 3件: ADRB1, ADRB2, ADRB3 💬
|
Propranolol hydrochloride Propranolol hydrochloride 💬Calcium signaling pathway
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬31. Calcium signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 32 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
ADRB1 3件: ADRB1, ADRB2, ADRB3 💬
|
Propranolol Propranolol 💬Calcium signaling pathway
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬31. Calcium signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 33 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
AGTR1 1件: AGTR1 💬Calcium signaling pathway
|
Irbesartan Irbesartan 💬Calcium signaling pathway
| Irbesartan | 057 6件: 57, 66, 167, 168, 222, 223 💬33. Calcium signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 34 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
AGTR1 1件: AGTR1 💬Calcium signaling pathway
|
Losartan potassium Losartan potassium 💬Calcium signaling pathway
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬34. Calcium signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 35 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
AGTR1 1件: AGTR1 💬Calcium signaling pathway
|
Losartan Losartan 💬Calcium signaling pathway
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬34. Calcium signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 36 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬Calcium signaling pathway
|
Verapamil hydrochloride Verapamil hydrochloride 💬Calcium signaling pathway
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 37 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬Calcium signaling pathway
|
Verapamil Verapamil 💬Calcium signaling pathway
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 38 | cAMP signaling pathway 💬 67 genes, 191 drugs (DrugBank) and 133 diseases |
ADRB1 1件: ADRB1 💬cAMP signaling pathway
|
Atenolol Atenolol 💬cAMP signaling pathway
| Atenolol | 167 1件: 167 💬38. cAMP signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 39 | cAMP signaling pathway 💬 67 genes, 191 drugs (DrugBank) and 133 diseases |
ADRB1 1件: ADRB1 💬cAMP signaling pathway
|
Nebivolol Nebivolol 💬cAMP signaling pathway
| Nebivolol | 017 4件: 17, 85, 113, 167 💬39. cAMP signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 40 | cAMP signaling pathway 💬 67 genes, 191 drugs (DrugBank) and 133 diseases |
ADRB1 1件: ADRB1 💬cAMP signaling pathway
|
Nebivolol hydrochloride Nebivolol hydrochloride 💬cAMP signaling pathway
| Nebivolol | 017 4件: 17, 85, 113, 167 💬39. cAMP signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 41 | cAMP signaling pathway 💬 67 genes, 191 drugs (DrugBank) and 133 diseases |
ADRB1 2件: ADRB1, ADRB2 💬
|
Propranolol hydrochloride Propranolol hydrochloride 💬cAMP signaling pathway
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬41. cAMP signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 42 | cAMP signaling pathway 💬 67 genes, 191 drugs (DrugBank) and 133 diseases |
ADRB1 2件: ADRB1, ADRB2 💬
|
Propranolol Propranolol 💬cAMP signaling pathway
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬41. cAMP signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 43 | cAMP signaling pathway 💬 67 genes, 191 drugs (DrugBank) and 133 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬cAMP signaling pathway
|
Verapamil hydrochloride Verapamil hydrochloride 💬cAMP signaling pathway
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 44 | cAMP signaling pathway 💬 67 genes, 191 drugs (DrugBank) and 133 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬cAMP signaling pathway
|
Verapamil Verapamil 💬cAMP signaling pathway
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 45 | Carbohydrate digestion and absorption 💬 13 genes, 22 drugs (DrugBank) and 40 diseases |
CACNA1D 1件: CACNA1D 💬Carbohydrate digestion and absorption
|
Verapamil hydrochloride Verapamil hydrochloride 💬Carbohydrate digestion and absorption
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 46 | Carbohydrate digestion and absorption 💬 13 genes, 22 drugs (DrugBank) and 40 diseases |
CACNA1D 1件: CACNA1D 💬Carbohydrate digestion and absorption
|
Verapamil Verapamil 💬Carbohydrate digestion and absorption
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 47 | Cardiac muscle contraction 💬 17 genes, 21 drugs (DrugBank) and 34 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬Cardiac muscle contraction
|
Verapamil hydrochloride Verapamil hydrochloride 💬Cardiac muscle contraction
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 48 | Cardiac muscle contraction 💬 17 genes, 21 drugs (DrugBank) and 34 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬Cardiac muscle contraction
|
Verapamil Verapamil 💬Cardiac muscle contraction
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 49 | Cellular senescence 💬 35 genes, 48 drugs (DrugBank) and 97 diseases |
CACNA1D 1件: CACNA1D 💬Cellular senescence
|
Verapamil hydrochloride Verapamil hydrochloride 💬Cellular senescence
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 50 | Cellular senescence 💬 35 genes, 48 drugs (DrugBank) and 97 diseases |
CACNA1D 1件: CACNA1D 💬Cellular senescence
|
Verapamil Verapamil 💬Cellular senescence
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 51 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
ADRB1 1件: ADRB1 💬cGMP-PKG signaling pathway
|
Atenolol Atenolol 💬cGMP-PKG signaling pathway
| Atenolol | 167 1件: 167 💬51. cGMP-PKG signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 52 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
ADRB1 1件: ADRB1 💬cGMP-PKG signaling pathway
|
Nebivolol Nebivolol 💬cGMP-PKG signaling pathway
| Nebivolol | 017 4件: 17, 85, 113, 167 💬52. cGMP-PKG signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 53 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
ADRB1 1件: ADRB1 💬cGMP-PKG signaling pathway
|
Nebivolol hydrochloride Nebivolol hydrochloride 💬cGMP-PKG signaling pathway
| Nebivolol | 017 4件: 17, 85, 113, 167 💬52. cGMP-PKG signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 54 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
ADRB1 3件: ADRB1, ADRB2, ADRB3 💬
|
Propranolol hydrochloride Propranolol hydrochloride 💬cGMP-PKG signaling pathway
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬54. cGMP-PKG signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 55 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
ADRB1 3件: ADRB1, ADRB2, ADRB3 💬
|
Propranolol Propranolol 💬cGMP-PKG signaling pathway
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬54. cGMP-PKG signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 56 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
AGTR1 1件: AGTR1 💬cGMP-PKG signaling pathway
|
Irbesartan Irbesartan 💬cGMP-PKG signaling pathway
| Irbesartan | 057 6件: 57, 66, 167, 168, 222, 223 💬56. cGMP-PKG signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 57 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
AGTR1 1件: AGTR1 💬cGMP-PKG signaling pathway
|
Losartan potassium Losartan potassium 💬cGMP-PKG signaling pathway
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬57. cGMP-PKG signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 58 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
AGTR1 1件: AGTR1 💬cGMP-PKG signaling pathway
|
Losartan Losartan 💬cGMP-PKG signaling pathway
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬57. cGMP-PKG signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 59 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬cGMP-PKG signaling pathway
|
Verapamil hydrochloride Verapamil hydrochloride 💬cGMP-PKG signaling pathway
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 60 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬cGMP-PKG signaling pathway
|
Verapamil Verapamil 💬cGMP-PKG signaling pathway
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 61 | Chagas disease 💬 32 genes, 59 drugs (DrugBank) and 88 diseases |
ACE 1件: ACE 💬Chagas disease
|
Perindopril erbumine Perindopril erbumine 💬Chagas disease
| Perindopril | 057 5件: 57, 58, 113, 167, 222 💬61. Chagas disease
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 62 | Chagas disease 💬 32 genes, 59 drugs (DrugBank) and 88 diseases |
ACE 1件: ACE 💬Chagas disease
|
Perindopril Perindopril 💬Chagas disease
| Perindopril | 057 5件: 57, 58, 113, 167, 222 💬61. Chagas disease
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 63 | Chagas disease 💬 32 genes, 59 drugs (DrugBank) and 88 diseases |
ACE 1件: ACE 💬Chagas disease
|
Perindopril arginine Perindopril arginine 💬Chagas disease
| Perindopril | 057 5件: 57, 58, 113, 167, 222 💬61. Chagas disease
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 64 | Chemical carcinogenesis - receptor activation 💬 41 genes, 140 drugs (DrugBank) and 133 diseases |
ADRB1 1件: ADRB1 💬Chemical carcinogenesis - receptor activation
|
Atenolol Atenolol 💬Chemical carcinogenesis - receptor activation
| Atenolol | 167 1件: 167 💬64. Chemical carcinogenesis - receptor activation
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 65 | Chemical carcinogenesis - receptor activation 💬 41 genes, 140 drugs (DrugBank) and 133 diseases |
ADRB1 1件: ADRB1 💬Chemical carcinogenesis - receptor activation
|
Nebivolol Nebivolol 💬Chemical carcinogenesis - receptor activation
| Nebivolol | 017 4件: 17, 85, 113, 167 💬65. Chemical carcinogenesis - receptor activation
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 66 | Chemical carcinogenesis - receptor activation 💬 41 genes, 140 drugs (DrugBank) and 133 diseases |
ADRB1 1件: ADRB1 💬Chemical carcinogenesis - receptor activation
|
Nebivolol hydrochloride Nebivolol hydrochloride 💬Chemical carcinogenesis - receptor activation
| Nebivolol | 017 4件: 17, 85, 113, 167 💬65. Chemical carcinogenesis - receptor activation
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 67 | Chemical carcinogenesis - receptor activation 💬 41 genes, 140 drugs (DrugBank) and 133 diseases |
ADRB1 3件: ADRB1, ADRB2, ADRB3 💬
|
Propranolol hydrochloride Propranolol hydrochloride 💬Chemical carcinogenesis - receptor activation
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬67. Chemical carcinogenesis - receptor activation
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 68 | Chemical carcinogenesis - receptor activation 💬 41 genes, 140 drugs (DrugBank) and 133 diseases |
ADRB1 3件: ADRB1, ADRB2, ADRB3 💬
|
Propranolol Propranolol 💬Chemical carcinogenesis - receptor activation
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬67. Chemical carcinogenesis - receptor activation
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 69 | Chemical carcinogenesis - receptor activation 💬 41 genes, 140 drugs (DrugBank) and 133 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬Chemical carcinogenesis - receptor activation
|
Verapamil hydrochloride Verapamil hydrochloride 💬Chemical carcinogenesis - receptor activation
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 70 | Chemical carcinogenesis - receptor activation 💬 41 genes, 140 drugs (DrugBank) and 133 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬Chemical carcinogenesis - receptor activation
|
Verapamil Verapamil 💬Chemical carcinogenesis - receptor activation
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 71 | Cholinergic synapse 💬 32 genes, 65 drugs (DrugBank) and 87 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬Cholinergic synapse
|
Verapamil hydrochloride Verapamil hydrochloride 💬Cholinergic synapse
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 72 | Cholinergic synapse 💬 32 genes, 65 drugs (DrugBank) and 87 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬Cholinergic synapse
|
Verapamil Verapamil 💬Cholinergic synapse
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 73 | Circadian entrainment 💬 22 genes, 42 drugs (DrugBank) and 62 diseases |
CACNA1C 2件: CACNA1C, CACNA1D 💬
|
Verapamil hydrochloride Verapamil hydrochloride 💬Circadian entrainment
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 74 | Circadian entrainment 💬 22 genes, 42 drugs (DrugBank) and 62 diseases |
CACNA1C 2件: CACNA1C, CACNA1D 💬
|
Verapamil Verapamil 💬Circadian entrainment
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 75 | Coronavirus disease 💬 56 genes, 115 drugs (DrugBank) and 109 diseases |
ACE 1件: ACE 💬Coronavirus disease
|
Perindopril erbumine Perindopril erbumine 💬Coronavirus disease
| Perindopril | 057 5件: 57, 58, 113, 167, 222 💬75. Coronavirus disease
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 76 | Coronavirus disease 💬 56 genes, 115 drugs (DrugBank) and 109 diseases |
ACE 1件: ACE 💬Coronavirus disease
|
Perindopril Perindopril 💬Coronavirus disease
| Perindopril | 057 5件: 57, 58, 113, 167, 222 💬75. Coronavirus disease
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 77 | Coronavirus disease 💬 56 genes, 115 drugs (DrugBank) and 109 diseases |
ACE 1件: ACE 💬Coronavirus disease
|
Perindopril arginine Perindopril arginine 💬Coronavirus disease
| Perindopril | 057 5件: 57, 58, 113, 167, 222 💬75. Coronavirus disease
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 78 | Coronavirus disease 💬 56 genes, 115 drugs (DrugBank) and 109 diseases |
AGTR1 1件: AGTR1 💬Coronavirus disease
|
Irbesartan Irbesartan 💬Coronavirus disease
| Irbesartan | 057 6件: 57, 66, 167, 168, 222, 223 💬78. Coronavirus disease
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 79 | Coronavirus disease 💬 56 genes, 115 drugs (DrugBank) and 109 diseases |
AGTR1 1件: AGTR1 💬Coronavirus disease
|
Losartan potassium Losartan potassium 💬Coronavirus disease
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬79. Coronavirus disease
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 80 | Coronavirus disease 💬 56 genes, 115 drugs (DrugBank) and 109 diseases |
AGTR1 1件: AGTR1 💬Coronavirus disease
|
Losartan Losartan 💬Coronavirus disease
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬79. Coronavirus disease
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 81 | Cortisol synthesis and secretion 💬 15 genes, 39 drugs (DrugBank) and 63 diseases |
AGTR1 1件: AGTR1 💬Cortisol synthesis and secretion
|
Irbesartan Irbesartan 💬Cortisol synthesis and secretion
| Irbesartan | 057 6件: 57, 66, 167, 168, 222, 223 💬81. Cortisol synthesis and secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 82 | Cortisol synthesis and secretion 💬 15 genes, 39 drugs (DrugBank) and 63 diseases |
AGTR1 1件: AGTR1 💬Cortisol synthesis and secretion
|
Losartan potassium Losartan potassium 💬Cortisol synthesis and secretion
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬82. Cortisol synthesis and secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 83 | Cortisol synthesis and secretion 💬 15 genes, 39 drugs (DrugBank) and 63 diseases |
AGTR1 1件: AGTR1 💬Cortisol synthesis and secretion
|
Losartan Losartan 💬Cortisol synthesis and secretion
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬82. Cortisol synthesis and secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 84 | Cortisol synthesis and secretion 💬 15 genes, 39 drugs (DrugBank) and 63 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬Cortisol synthesis and secretion
|
Verapamil hydrochloride Verapamil hydrochloride 💬Cortisol synthesis and secretion
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 85 | Cortisol synthesis and secretion 💬 15 genes, 39 drugs (DrugBank) and 63 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬Cortisol synthesis and secretion
|
Verapamil Verapamil 💬Cortisol synthesis and secretion
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 86 | Cushing syndrome 💬 23 genes, 56 drugs (DrugBank) and 71 diseases |
AGTR1 1件: AGTR1 💬Cushing syndrome
|
Irbesartan Irbesartan 💬Cushing syndrome
| Irbesartan | 057 6件: 57, 66, 167, 168, 222, 223 💬86. Cushing syndrome
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 87 | Cushing syndrome 💬 23 genes, 56 drugs (DrugBank) and 71 diseases |
AGTR1 1件: AGTR1 💬Cushing syndrome
|
Losartan potassium Losartan potassium 💬Cushing syndrome
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬87. Cushing syndrome
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 88 | Cushing syndrome 💬 23 genes, 56 drugs (DrugBank) and 71 diseases |
AGTR1 1件: AGTR1 💬Cushing syndrome
|
Losartan Losartan 💬Cushing syndrome
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬87. Cushing syndrome
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 89 | Cushing syndrome 💬 23 genes, 56 drugs (DrugBank) and 71 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬Cushing syndrome
|
Verapamil hydrochloride Verapamil hydrochloride 💬Cushing syndrome
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 90 | Cushing syndrome 💬 23 genes, 56 drugs (DrugBank) and 71 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬Cushing syndrome
|
Verapamil Verapamil 💬Cushing syndrome
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 91 | Diabetic cardiomyopathy 💬 25 genes, 48 drugs (DrugBank) and 80 diseases |
ACE 1件: ACE 💬Diabetic cardiomyopathy
|
Perindopril erbumine Perindopril erbumine 💬Diabetic cardiomyopathy
| Perindopril | 057 5件: 57, 58, 113, 167, 222 💬91. Diabetic cardiomyopathy
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 92 | Diabetic cardiomyopathy 💬 25 genes, 48 drugs (DrugBank) and 80 diseases |
ACE 1件: ACE 💬Diabetic cardiomyopathy
|
Perindopril Perindopril 💬Diabetic cardiomyopathy
| Perindopril | 057 5件: 57, 58, 113, 167, 222 💬91. Diabetic cardiomyopathy
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 93 | Diabetic cardiomyopathy 💬 25 genes, 48 drugs (DrugBank) and 80 diseases |
ACE 1件: ACE 💬Diabetic cardiomyopathy
|
Perindopril arginine Perindopril arginine 💬Diabetic cardiomyopathy
| Perindopril | 057 5件: 57, 58, 113, 167, 222 💬91. Diabetic cardiomyopathy
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 94 | Diabetic cardiomyopathy 💬 25 genes, 48 drugs (DrugBank) and 80 diseases |
AGTR1 1件: AGTR1 💬Diabetic cardiomyopathy
|
Irbesartan Irbesartan 💬Diabetic cardiomyopathy
| Irbesartan | 057 6件: 57, 66, 167, 168, 222, 223 💬94. Diabetic cardiomyopathy
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 95 | Diabetic cardiomyopathy 💬 25 genes, 48 drugs (DrugBank) and 80 diseases |
AGTR1 1件: AGTR1 💬Diabetic cardiomyopathy
|
Losartan potassium Losartan potassium 💬Diabetic cardiomyopathy
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬95. Diabetic cardiomyopathy
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 96 | Diabetic cardiomyopathy 💬 25 genes, 48 drugs (DrugBank) and 80 diseases |
AGTR1 1件: AGTR1 💬Diabetic cardiomyopathy
|
Losartan Losartan 💬Diabetic cardiomyopathy
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬95. Diabetic cardiomyopathy
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 97 | Diabetic cardiomyopathy 💬 25 genes, 48 drugs (DrugBank) and 80 diseases |
REN 1件: REN 💬Diabetic cardiomyopathy
|
Aliskiren Aliskiren 💬Diabetic cardiomyopathy
| Aliskiren | 066 4件: 66, 167, 222, 223 💬97. Diabetic cardiomyopathy
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 98 | Diabetic cardiomyopathy 💬 25 genes, 48 drugs (DrugBank) and 80 diseases |
REN 1件: REN 💬Diabetic cardiomyopathy
|
Aliskiren fumarate Aliskiren fumarate 💬Diabetic cardiomyopathy
| Aliskiren | 066 4件: 66, 167, 222, 223 💬97. Diabetic cardiomyopathy
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 99 | Dilated cardiomyopathy 💬 23 genes, 61 drugs (DrugBank) and 93 diseases |
ADRB1 1件: ADRB1 💬Dilated cardiomyopathy
|
Atenolol Atenolol 💬Dilated cardiomyopathy
| Atenolol | 167 1件: 167 💬99. Dilated cardiomyopathy
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 100 | Dilated cardiomyopathy 💬 23 genes, 61 drugs (DrugBank) and 93 diseases |
ADRB1 1件: ADRB1 💬Dilated cardiomyopathy
|
Nebivolol Nebivolol 💬Dilated cardiomyopathy
| Nebivolol | 017 4件: 17, 85, 113, 167 💬100. Dilated cardiomyopathy
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 101 | Dilated cardiomyopathy 💬 23 genes, 61 drugs (DrugBank) and 93 diseases |
ADRB1 1件: ADRB1 💬Dilated cardiomyopathy
|
Nebivolol hydrochloride Nebivolol hydrochloride 💬Dilated cardiomyopathy
| Nebivolol | 017 4件: 17, 85, 113, 167 💬100. Dilated cardiomyopathy
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 102 | Dilated cardiomyopathy 💬 23 genes, 61 drugs (DrugBank) and 93 diseases |
ADRB1 1件: ADRB1 💬Dilated cardiomyopathy
|
Propranolol hydrochloride Propranolol hydrochloride 💬Dilated cardiomyopathy
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬102. Dilated cardiomyopathy
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 103 | Dilated cardiomyopathy 💬 23 genes, 61 drugs (DrugBank) and 93 diseases |
ADRB1 1件: ADRB1 💬Dilated cardiomyopathy
|
Propranolol Propranolol 💬Dilated cardiomyopathy
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬102. Dilated cardiomyopathy
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 104 | Dilated cardiomyopathy 💬 23 genes, 61 drugs (DrugBank) and 93 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬Dilated cardiomyopathy
|
Verapamil hydrochloride Verapamil hydrochloride 💬Dilated cardiomyopathy
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 105 | Dilated cardiomyopathy 💬 23 genes, 61 drugs (DrugBank) and 93 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬Dilated cardiomyopathy
|
Verapamil Verapamil 💬Dilated cardiomyopathy
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 106 | Dopaminergic synapse 💬 33 genes, 105 drugs (DrugBank) and 105 diseases |
CACNA1C 2件: CACNA1C, CACNA1D 💬
|
Verapamil hydrochloride Verapamil hydrochloride 💬Dopaminergic synapse
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 107 | Dopaminergic synapse 💬 33 genes, 105 drugs (DrugBank) and 105 diseases |
CACNA1C 2件: CACNA1C, CACNA1D 💬
|
Verapamil Verapamil 💬Dopaminergic synapse
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 108 | GABAergic synapse 💬 29 genes, 42 drugs (DrugBank) and 57 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬GABAergic synapse
|
Verapamil hydrochloride Verapamil hydrochloride 💬GABAergic synapse
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 109 | GABAergic synapse 💬 29 genes, 42 drugs (DrugBank) and 57 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬GABAergic synapse
|
Verapamil Verapamil 💬GABAergic synapse
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 110 | Gap junction 💬 27 genes, 103 drugs (DrugBank) and 87 diseases |
ADRB1 1件: ADRB1 💬Gap junction
|
Atenolol Atenolol 💬Gap junction
| Atenolol | 167 1件: 167 💬110. Gap junction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 111 | Gap junction 💬 27 genes, 103 drugs (DrugBank) and 87 diseases |
ADRB1 1件: ADRB1 💬Gap junction
|
Nebivolol Nebivolol 💬Gap junction
| Nebivolol | 017 4件: 17, 85, 113, 167 💬111. Gap junction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 112 | Gap junction 💬 27 genes, 103 drugs (DrugBank) and 87 diseases |
ADRB1 1件: ADRB1 💬Gap junction
|
Nebivolol hydrochloride Nebivolol hydrochloride 💬Gap junction
| Nebivolol | 017 4件: 17, 85, 113, 167 💬111. Gap junction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 113 | Gap junction 💬 27 genes, 103 drugs (DrugBank) and 87 diseases |
ADRB1 1件: ADRB1 💬Gap junction
|
Propranolol hydrochloride Propranolol hydrochloride 💬Gap junction
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬113. Gap junction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 114 | Gap junction 💬 27 genes, 103 drugs (DrugBank) and 87 diseases |
ADRB1 1件: ADRB1 💬Gap junction
|
Propranolol Propranolol 💬Gap junction
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬113. Gap junction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 115 | Glutamatergic synapse 💬 23 genes, 32 drugs (DrugBank) and 82 diseases |
CACNA1C 2件: CACNA1C, CACNA1D 💬
|
Verapamil hydrochloride Verapamil hydrochloride 💬Glutamatergic synapse
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 116 | Glutamatergic synapse 💬 23 genes, 32 drugs (DrugBank) and 82 diseases |
CACNA1C 2件: CACNA1C, CACNA1D 💬
|
Verapamil Verapamil 💬Glutamatergic synapse
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 117 | GnRH secretion 💬 27 genes, 49 drugs (DrugBank) and 62 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬GnRH secretion
|
Verapamil hydrochloride Verapamil hydrochloride 💬GnRH secretion
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 118 | GnRH secretion 💬 27 genes, 49 drugs (DrugBank) and 62 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬GnRH secretion
|
Verapamil Verapamil 💬GnRH secretion
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 119 | GnRH signaling pathway 💬 16 genes, 40 drugs (DrugBank) and 47 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬GnRH signaling pathway
|
Verapamil hydrochloride Verapamil hydrochloride 💬GnRH signaling pathway
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 120 | GnRH signaling pathway 💬 16 genes, 40 drugs (DrugBank) and 47 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬GnRH signaling pathway
|
Verapamil Verapamil 💬GnRH signaling pathway
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 121 | Growth hormone synthesis, secretion and action 💬 23 genes, 49 drugs (DrugBank) and 97 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬Growth hormone synthesis, secretion and action
|
Verapamil hydrochloride Verapamil hydrochloride 💬Growth hormone synthesis, secretion and action
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 122 | Growth hormone synthesis, secretion and action 💬 23 genes, 49 drugs (DrugBank) and 97 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬Growth hormone synthesis, secretion and action
|
Verapamil Verapamil 💬Growth hormone synthesis, secretion and action
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 123 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
ADRB1 1件: ADRB1 💬Hormone signaling
|
Atenolol Atenolol 💬Hormone signaling
| Atenolol | 167 1件: 167 💬123. Hormone signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 124 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
ADRB1 1件: ADRB1 💬Hormone signaling
|
Nebivolol Nebivolol 💬Hormone signaling
| Nebivolol | 017 4件: 17, 85, 113, 167 💬124. Hormone signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 125 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
ADRB1 1件: ADRB1 💬Hormone signaling
|
Nebivolol hydrochloride Nebivolol hydrochloride 💬Hormone signaling
| Nebivolol | 017 4件: 17, 85, 113, 167 💬124. Hormone signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 126 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
ADRB1 3件: ADRB1, ADRB2, ADRB3 💬
|
Propranolol hydrochloride Propranolol hydrochloride 💬Hormone signaling
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬126. Hormone signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 127 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
ADRB1 3件: ADRB1, ADRB2, ADRB3 💬
|
Propranolol Propranolol 💬Hormone signaling
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬126. Hormone signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 128 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
AGTR1 1件: AGTR1 💬Hormone signaling
|
Irbesartan Irbesartan 💬Hormone signaling
| Irbesartan | 057 6件: 57, 66, 167, 168, 222, 223 💬128. Hormone signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 129 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
AGTR1 1件: AGTR1 💬Hormone signaling
|
Losartan potassium Losartan potassium 💬Hormone signaling
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬129. Hormone signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 130 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
AGTR1 1件: AGTR1 💬Hormone signaling
|
Losartan Losartan 💬Hormone signaling
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬129. Hormone signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 131 | Hypertrophic cardiomyopathy 💬 26 genes, 57 drugs (DrugBank) and 97 diseases |
ACE 1件: ACE 💬Hypertrophic cardiomyopathy
|
Perindopril erbumine Perindopril erbumine 💬Hypertrophic cardiomyopathy
| Perindopril | 057 5件: 57, 58, 113, 167, 222 💬131. Hypertrophic cardiomyopathy
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 132 | Hypertrophic cardiomyopathy 💬 26 genes, 57 drugs (DrugBank) and 97 diseases |
ACE 1件: ACE 💬Hypertrophic cardiomyopathy
|
Perindopril Perindopril 💬Hypertrophic cardiomyopathy
| Perindopril | 057 5件: 57, 58, 113, 167, 222 💬131. Hypertrophic cardiomyopathy
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 133 | Hypertrophic cardiomyopathy 💬 26 genes, 57 drugs (DrugBank) and 97 diseases |
ACE 1件: ACE 💬Hypertrophic cardiomyopathy
|
Perindopril arginine Perindopril arginine 💬Hypertrophic cardiomyopathy
| Perindopril | 057 5件: 57, 58, 113, 167, 222 💬131. Hypertrophic cardiomyopathy
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 134 | Hypertrophic cardiomyopathy 💬 26 genes, 57 drugs (DrugBank) and 97 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬Hypertrophic cardiomyopathy
|
Verapamil hydrochloride Verapamil hydrochloride 💬Hypertrophic cardiomyopathy
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 135 | Hypertrophic cardiomyopathy 💬 26 genes, 57 drugs (DrugBank) and 97 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬Hypertrophic cardiomyopathy
|
Verapamil Verapamil 💬Hypertrophic cardiomyopathy
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 136 | Insulin secretion 💬 16 genes, 51 drugs (DrugBank) and 61 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬Insulin secretion
|
Verapamil hydrochloride Verapamil hydrochloride 💬Insulin secretion
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 137 | Insulin secretion 💬 16 genes, 51 drugs (DrugBank) and 61 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬Insulin secretion
|
Verapamil Verapamil 💬Insulin secretion
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 138 | Long-term potentiation 💬 18 genes, 37 drugs (DrugBank) and 87 diseases |
CACNA1C 1件: CACNA1C 💬Long-term potentiation
|
Verapamil hydrochloride Verapamil hydrochloride 💬Long-term potentiation
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 139 | Long-term potentiation 💬 18 genes, 37 drugs (DrugBank) and 87 diseases |
CACNA1C 1件: CACNA1C 💬Long-term potentiation
|
Verapamil Verapamil 💬Long-term potentiation
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 140 | MAPK signaling pathway 💬 70 genes, 101 drugs (DrugBank) and 117 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬MAPK signaling pathway
|
Verapamil hydrochloride Verapamil hydrochloride 💬MAPK signaling pathway
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 141 | MAPK signaling pathway 💬 70 genes, 101 drugs (DrugBank) and 117 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬MAPK signaling pathway
|
Verapamil Verapamil 💬MAPK signaling pathway
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 142 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 118 diseases |
ADRB1 1件: ADRB1 💬Neuroactive ligand signaling
|
Atenolol Atenolol 💬Neuroactive ligand signaling
| Atenolol | 167 1件: 167 💬142. Neuroactive ligand signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 143 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 118 diseases |
ADRB1 1件: ADRB1 💬Neuroactive ligand signaling
|
Nebivolol Nebivolol 💬Neuroactive ligand signaling
| Nebivolol | 017 4件: 17, 85, 113, 167 💬143. Neuroactive ligand signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 144 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 118 diseases |
ADRB1 1件: ADRB1 💬Neuroactive ligand signaling
|
Nebivolol hydrochloride Nebivolol hydrochloride 💬Neuroactive ligand signaling
| Nebivolol | 017 4件: 17, 85, 113, 167 💬143. Neuroactive ligand signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 145 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 118 diseases |
ADRB1 2件: ADRB1, ADRB2 💬
|
Propranolol hydrochloride Propranolol hydrochloride 💬Neuroactive ligand signaling
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬145. Neuroactive ligand signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 146 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 118 diseases |
ADRB1 2件: ADRB1, ADRB2 💬
|
Propranolol Propranolol 💬Neuroactive ligand signaling
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬145. Neuroactive ligand signaling
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 147 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
ADRB1 1件: ADRB1 💬Neuroactive ligand-receptor interaction
|
Atenolol Atenolol 💬Neuroactive ligand-receptor interaction
| Atenolol | 167 1件: 167 💬147. Neuroactive ligand-receptor interaction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 148 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
ADRB1 1件: ADRB1 💬Neuroactive ligand-receptor interaction
|
Nebivolol Nebivolol 💬Neuroactive ligand-receptor interaction
| Nebivolol | 017 4件: 17, 85, 113, 167 💬148. Neuroactive ligand-receptor interaction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 149 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
ADRB1 1件: ADRB1 💬Neuroactive ligand-receptor interaction
|
Nebivolol hydrochloride Nebivolol hydrochloride 💬Neuroactive ligand-receptor interaction
| Nebivolol | 017 4件: 17, 85, 113, 167 💬148. Neuroactive ligand-receptor interaction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 150 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
ADRB1 3件: ADRB1, ADRB2, ADRB3 💬
|
Propranolol hydrochloride Propranolol hydrochloride 💬Neuroactive ligand-receptor interaction
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬150. Neuroactive ligand-receptor interaction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 151 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
ADRB1 3件: ADRB1, ADRB2, ADRB3 💬
|
Propranolol Propranolol 💬Neuroactive ligand-receptor interaction
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬150. Neuroactive ligand-receptor interaction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 152 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
AGTR1 1件: AGTR1 💬Neuroactive ligand-receptor interaction
|
Irbesartan Irbesartan 💬Neuroactive ligand-receptor interaction
| Irbesartan | 057 6件: 57, 66, 167, 168, 222, 223 💬152. Neuroactive ligand-receptor interaction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 153 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
AGTR1 1件: AGTR1 💬Neuroactive ligand-receptor interaction
|
Losartan potassium Losartan potassium 💬Neuroactive ligand-receptor interaction
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬153. Neuroactive ligand-receptor interaction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 154 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
AGTR1 1件: AGTR1 💬Neuroactive ligand-receptor interaction
|
Losartan Losartan 💬Neuroactive ligand-receptor interaction
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬153. Neuroactive ligand-receptor interaction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 155 | Oxytocin signaling pathway 💬 34 genes, 85 drugs (DrugBank) and 112 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬Oxytocin signaling pathway
|
Verapamil hydrochloride Verapamil hydrochloride 💬Oxytocin signaling pathway
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 156 | Oxytocin signaling pathway 💬 34 genes, 85 drugs (DrugBank) and 112 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬Oxytocin signaling pathway
|
Verapamil Verapamil 💬Oxytocin signaling pathway
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 157 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
AGTR1 1件: AGTR1 💬Pathways in cancer
|
Irbesartan Irbesartan 💬Pathways in cancer
| Irbesartan | 057 6件: 57, 66, 167, 168, 222, 223 💬157. Pathways in cancer
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 158 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
AGTR1 1件: AGTR1 💬Pathways in cancer
|
Losartan potassium Losartan potassium 💬Pathways in cancer
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬158. Pathways in cancer
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 159 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
AGTR1 1件: AGTR1 💬Pathways in cancer
|
Losartan Losartan 💬Pathways in cancer
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬158. Pathways in cancer
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 160 | Pathways of neurodegeneration - multiple diseases 💬 64 genes, 143 drugs (DrugBank) and 141 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬Pathways of neurodegeneration - multiple diseases
|
Verapamil hydrochloride Verapamil hydrochloride 💬Pathways of neurodegeneration - multiple diseases
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬160. Pathways of neurodegeneration - multiple diseases |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 161 | Pathways of neurodegeneration - multiple diseases 💬 64 genes, 143 drugs (DrugBank) and 141 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬Pathways of neurodegeneration - multiple diseases
|
Verapamil Verapamil 💬Pathways of neurodegeneration - multiple diseases
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬160. Pathways of neurodegeneration - multiple diseases |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 162 | Phospholipase D signaling pathway 💬 24 genes, 60 drugs (DrugBank) and 84 diseases |
AGTR1 1件: AGTR1 💬Phospholipase D signaling pathway
|
Irbesartan Irbesartan 💬Phospholipase D signaling pathway
| Irbesartan | 057 6件: 57, 66, 167, 168, 222, 223 💬162. Phospholipase D signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 163 | Phospholipase D signaling pathway 💬 24 genes, 60 drugs (DrugBank) and 84 diseases |
AGTR1 1件: AGTR1 💬Phospholipase D signaling pathway
|
Losartan potassium Losartan potassium 💬Phospholipase D signaling pathway
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬163. Phospholipase D signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 164 | Phospholipase D signaling pathway 💬 24 genes, 60 drugs (DrugBank) and 84 diseases |
AGTR1 1件: AGTR1 💬Phospholipase D signaling pathway
|
Losartan Losartan 💬Phospholipase D signaling pathway
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬163. Phospholipase D signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 165 | Prion disease 💬 41 genes, 77 drugs (DrugBank) and 121 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬Prion disease
|
Verapamil hydrochloride Verapamil hydrochloride 💬Prion disease
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 166 | Prion disease 💬 41 genes, 77 drugs (DrugBank) and 121 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬Prion disease
|
Verapamil Verapamil 💬Prion disease
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 167 | Regulation of lipolysis in adipocytes 💬 13 genes, 72 drugs (DrugBank) and 80 diseases |
ADRB1 1件: ADRB1 💬Regulation of lipolysis in adipocytes
|
Atenolol Atenolol 💬Regulation of lipolysis in adipocytes
| Atenolol | 167 1件: 167 💬167. Regulation of lipolysis in adipocytes
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 168 | Regulation of lipolysis in adipocytes 💬 13 genes, 72 drugs (DrugBank) and 80 diseases |
ADRB1 1件: ADRB1 💬Regulation of lipolysis in adipocytes
|
Nebivolol Nebivolol 💬Regulation of lipolysis in adipocytes
| Nebivolol | 017 4件: 17, 85, 113, 167 💬168. Regulation of lipolysis in adipocytes
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 169 | Regulation of lipolysis in adipocytes 💬 13 genes, 72 drugs (DrugBank) and 80 diseases |
ADRB1 1件: ADRB1 💬Regulation of lipolysis in adipocytes
|
Nebivolol hydrochloride Nebivolol hydrochloride 💬Regulation of lipolysis in adipocytes
| Nebivolol | 017 4件: 17, 85, 113, 167 💬168. Regulation of lipolysis in adipocytes
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 170 | Regulation of lipolysis in adipocytes 💬 13 genes, 72 drugs (DrugBank) and 80 diseases |
ADRB1 3件: ADRB1, ADRB2, ADRB3 💬
|
Propranolol hydrochloride Propranolol hydrochloride 💬Regulation of lipolysis in adipocytes
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬170. Regulation of lipolysis in adipocytes
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 171 | Regulation of lipolysis in adipocytes 💬 13 genes, 72 drugs (DrugBank) and 80 diseases |
ADRB1 3件: ADRB1, ADRB2, ADRB3 💬
|
Propranolol Propranolol 💬Regulation of lipolysis in adipocytes
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬170. Regulation of lipolysis in adipocytes
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 172 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
ACE 1件: ACE 💬Renin secretion
|
Perindopril erbumine Perindopril erbumine 💬Renin secretion
| Perindopril | 057 5件: 57, 58, 113, 167, 222 💬172. Renin secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 173 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
ACE 1件: ACE 💬Renin secretion
|
Perindopril Perindopril 💬Renin secretion
| Perindopril | 057 5件: 57, 58, 113, 167, 222 💬172. Renin secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 174 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
ACE 1件: ACE 💬Renin secretion
|
Perindopril arginine Perindopril arginine 💬Renin secretion
| Perindopril | 057 5件: 57, 58, 113, 167, 222 💬172. Renin secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 175 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
ADRB1 1件: ADRB1 💬Renin secretion
|
Atenolol Atenolol 💬Renin secretion
| Atenolol | 167 1件: 167 💬175. Renin secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 176 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
ADRB1 1件: ADRB1 💬Renin secretion
|
Nebivolol Nebivolol 💬Renin secretion
| Nebivolol | 017 4件: 17, 85, 113, 167 💬176. Renin secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 177 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
ADRB1 1件: ADRB1 💬Renin secretion
|
Nebivolol hydrochloride Nebivolol hydrochloride 💬Renin secretion
| Nebivolol | 017 4件: 17, 85, 113, 167 💬176. Renin secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 178 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
ADRB1 3件: ADRB1, ADRB2, ADRB3 💬
|
Propranolol hydrochloride Propranolol hydrochloride 💬Renin secretion
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬178. Renin secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 179 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
ADRB1 3件: ADRB1, ADRB2, ADRB3 💬
|
Propranolol Propranolol 💬Renin secretion
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬178. Renin secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 180 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
AGTR1 1件: AGTR1 💬Renin secretion
|
Irbesartan Irbesartan 💬Renin secretion
| Irbesartan | 057 6件: 57, 66, 167, 168, 222, 223 💬180. Renin secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 181 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
AGTR1 1件: AGTR1 💬Renin secretion
|
Losartan potassium Losartan potassium 💬Renin secretion
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬181. Renin secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 182 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
AGTR1 1件: AGTR1 💬Renin secretion
|
Losartan Losartan 💬Renin secretion
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬181. Renin secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 183 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬Renin secretion
|
Verapamil hydrochloride Verapamil hydrochloride 💬Renin secretion
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 184 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬Renin secretion
|
Verapamil Verapamil 💬Renin secretion
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 185 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
REN 1件: REN 💬Renin secretion
|
Aliskiren Aliskiren 💬Renin secretion
| Aliskiren | 066 4件: 66, 167, 222, 223 💬185. Renin secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 186 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
REN 1件: REN 💬Renin secretion
|
Aliskiren fumarate Aliskiren fumarate 💬Renin secretion
| Aliskiren | 066 4件: 66, 167, 222, 223 💬185. Renin secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 187 | Renin-angiotensin system 💬 6 genes, 22 drugs (DrugBank) and 33 diseases |
ACE 1件: ACE 💬Renin-angiotensin system
|
Perindopril erbumine Perindopril erbumine 💬Renin-angiotensin system
| Perindopril | 057 5件: 57, 58, 113, 167, 222 💬187. Renin-angiotensin system
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 188 | Renin-angiotensin system 💬 6 genes, 22 drugs (DrugBank) and 33 diseases |
ACE 1件: ACE 💬Renin-angiotensin system
|
Perindopril Perindopril 💬Renin-angiotensin system
| Perindopril | 057 5件: 57, 58, 113, 167, 222 💬187. Renin-angiotensin system
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 189 | Renin-angiotensin system 💬 6 genes, 22 drugs (DrugBank) and 33 diseases |
ACE 1件: ACE 💬Renin-angiotensin system
|
Perindopril arginine Perindopril arginine 💬Renin-angiotensin system
| Perindopril | 057 5件: 57, 58, 113, 167, 222 💬187. Renin-angiotensin system
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 190 | Renin-angiotensin system 💬 6 genes, 22 drugs (DrugBank) and 33 diseases |
AGTR1 1件: AGTR1 💬Renin-angiotensin system
|
Irbesartan Irbesartan 💬Renin-angiotensin system
| Irbesartan | 057 6件: 57, 66, 167, 168, 222, 223 💬190. Renin-angiotensin system
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 191 | Renin-angiotensin system 💬 6 genes, 22 drugs (DrugBank) and 33 diseases |
AGTR1 1件: AGTR1 💬Renin-angiotensin system
|
Losartan potassium Losartan potassium 💬Renin-angiotensin system
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬191. Renin-angiotensin system
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 192 | Renin-angiotensin system 💬 6 genes, 22 drugs (DrugBank) and 33 diseases |
AGTR1 1件: AGTR1 💬Renin-angiotensin system
|
Losartan Losartan 💬Renin-angiotensin system
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬191. Renin-angiotensin system
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 193 | Renin-angiotensin system 💬 6 genes, 22 drugs (DrugBank) and 33 diseases |
REN 1件: REN 💬Renin-angiotensin system
|
Aliskiren Aliskiren 💬Renin-angiotensin system
| Aliskiren | 066 4件: 66, 167, 222, 223 💬193. Renin-angiotensin system
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 194 | Renin-angiotensin system 💬 6 genes, 22 drugs (DrugBank) and 33 diseases |
REN 1件: REN 💬Renin-angiotensin system
|
Aliskiren fumarate Aliskiren fumarate 💬Renin-angiotensin system
| Aliskiren | 066 4件: 66, 167, 222, 223 💬193. Renin-angiotensin system
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 195 | Retrograde endocannabinoid signaling 💬 34 genes, 70 drugs (DrugBank) and 74 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬Retrograde endocannabinoid signaling
|
Verapamil hydrochloride Verapamil hydrochloride 💬Retrograde endocannabinoid signaling
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 196 | Retrograde endocannabinoid signaling 💬 34 genes, 70 drugs (DrugBank) and 74 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬Retrograde endocannabinoid signaling
|
Verapamil Verapamil 💬Retrograde endocannabinoid signaling
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 197 | Salivary secretion 💬 20 genes, 75 drugs (DrugBank) and 75 diseases |
ADRB1 1件: ADRB1 💬Salivary secretion
|
Atenolol Atenolol 💬Salivary secretion
| Atenolol | 167 1件: 167 💬197. Salivary secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 198 | Salivary secretion 💬 20 genes, 75 drugs (DrugBank) and 75 diseases |
ADRB1 1件: ADRB1 💬Salivary secretion
|
Nebivolol Nebivolol 💬Salivary secretion
| Nebivolol | 017 4件: 17, 85, 113, 167 💬198. Salivary secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 199 | Salivary secretion 💬 20 genes, 75 drugs (DrugBank) and 75 diseases |
ADRB1 1件: ADRB1 💬Salivary secretion
|
Nebivolol hydrochloride Nebivolol hydrochloride 💬Salivary secretion
| Nebivolol | 017 4件: 17, 85, 113, 167 💬198. Salivary secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 200 | Salivary secretion 💬 20 genes, 75 drugs (DrugBank) and 75 diseases |
ADRB1 3件: ADRB1, ADRB2, ADRB3 💬
|
Propranolol hydrochloride Propranolol hydrochloride 💬Salivary secretion
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬200. Salivary secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 201 | Salivary secretion 💬 20 genes, 75 drugs (DrugBank) and 75 diseases |
ADRB1 3件: ADRB1, ADRB2, ADRB3 💬
|
Propranolol Propranolol 💬Salivary secretion
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬200. Salivary secretion
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 202 | Serotonergic synapse 💬 40 genes, 130 drugs (DrugBank) and 89 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬Serotonergic synapse
|
Verapamil hydrochloride Verapamil hydrochloride 💬Serotonergic synapse
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 203 | Serotonergic synapse 💬 40 genes, 130 drugs (DrugBank) and 89 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬Serotonergic synapse
|
Verapamil Verapamil 💬Serotonergic synapse
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 204 | Taste transduction 💬 29 genes, 93 drugs (DrugBank) and 78 diseases |
CACNA1C 1件: CACNA1C 💬Taste transduction
|
Verapamil hydrochloride Verapamil hydrochloride 💬Taste transduction
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 205 | Taste transduction 💬 29 genes, 93 drugs (DrugBank) and 78 diseases |
CACNA1C 1件: CACNA1C 💬Taste transduction
|
Verapamil Verapamil 💬Taste transduction
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 206 | Thermogenesis 💬 17 genes, 31 drugs (DrugBank) and 89 diseases |
ADRB3 1件: ADRB3 💬Thermogenesis
|
Propranolol hydrochloride Propranolol hydrochloride 💬Thermogenesis
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬206. Thermogenesis
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 207 | Thermogenesis 💬 17 genes, 31 drugs (DrugBank) and 89 diseases |
ADRB3 1件: ADRB3 💬Thermogenesis
|
Propranolol Propranolol 💬Thermogenesis
| Propranolol | 006 7件: 6 , 158, 167, 215, 216, 227, 278 💬206. Thermogenesis
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 208 | Tight junction 💬 13 genes, 38 drugs (DrugBank) and 54 diseases |
CACNA1D 1件: CACNA1D 💬Tight junction
|
Verapamil hydrochloride Verapamil hydrochloride 💬Tight junction
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 209 | Tight junction 💬 13 genes, 38 drugs (DrugBank) and 54 diseases |
CACNA1D 1件: CACNA1D 💬Tight junction
|
Verapamil Verapamil 💬Tight junction
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 210 | Type II diabetes mellitus 💬 15 genes, 44 drugs (DrugBank) and 100 diseases |
CACNA1C 2件: CACNA1C, CACNA1D 💬
|
Verapamil hydrochloride Verapamil hydrochloride 💬Type II diabetes mellitus
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 211 | Type II diabetes mellitus 💬 15 genes, 44 drugs (DrugBank) and 100 diseases |
CACNA1C 2件: CACNA1C, CACNA1D 💬
|
Verapamil Verapamil 💬Type II diabetes mellitus
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 212 | Vascular smooth muscle contraction 💬 32 genes, 95 drugs (DrugBank) and 74 diseases |
AGTR1 1件: AGTR1 💬Vascular smooth muscle contraction
|
Irbesartan Irbesartan 💬Vascular smooth muscle contraction
| Irbesartan | 057 6件: 57, 66, 167, 168, 222, 223 💬212. Vascular smooth muscle contraction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 213 | Vascular smooth muscle contraction 💬 32 genes, 95 drugs (DrugBank) and 74 diseases |
AGTR1 1件: AGTR1 💬Vascular smooth muscle contraction
|
Losartan potassium Losartan potassium 💬Vascular smooth muscle contraction
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬213. Vascular smooth muscle contraction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 214 | Vascular smooth muscle contraction 💬 32 genes, 95 drugs (DrugBank) and 74 diseases |
AGTR1 1件: AGTR1 💬Vascular smooth muscle contraction
|
Losartan Losartan 💬Vascular smooth muscle contraction
| Losartan | 017 20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬213. Vascular smooth muscle contraction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 215 | Vascular smooth muscle contraction 💬 32 genes, 95 drugs (DrugBank) and 74 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬Vascular smooth muscle contraction
|
Verapamil hydrochloride Verapamil hydrochloride 💬Vascular smooth muscle contraction
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 216 | Vascular smooth muscle contraction 💬 32 genes, 95 drugs (DrugBank) and 74 diseases |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬Vascular smooth muscle contraction
|
Verapamil Verapamil 💬Vascular smooth muscle contraction
| Verapamil | 057 5件: 57, 58, 96, 140, 167 💬
|
Adrenergic signaling in cardiomyocytes
31 genes, 86 drugs (DrugBank) and 81 diseases
AGE-RAGE signaling pathway in diabetic complications
28 genes, 58 drugs (DrugBank) and 100 diseases
Aldosterone synthesis and secretion
20 genes, 43 drugs (DrugBank) and 63 diseases
Alzheimer disease
59 genes, 136 drugs (DrugBank) and 139 diseases
Amphetamine addiction
25 genes, 58 drugs (DrugBank) and 92 diseases
Apelin signaling pathway
18 genes, 37 drugs (DrugBank) and 81 diseases
Arrhythmogenic right ventricular cardiomyopathy
14 genes, 30 drugs (DrugBank) and 33 diseases
Calcium signaling pathway
82 genes, 215 drugs (DrugBank) and 140 diseases
cAMP signaling pathway
67 genes, 191 drugs (DrugBank) and 133 diseases
Carbohydrate digestion and absorption
13 genes, 22 drugs (DrugBank) and 40 diseases
Cardiac muscle contraction
17 genes, 21 drugs (DrugBank) and 34 diseases
Cellular senescence
35 genes, 48 drugs (DrugBank) and 97 diseases
cGMP-PKG signaling pathway
48 genes, 132 drugs (DrugBank) and 123 diseases
Chagas disease
32 genes, 59 drugs (DrugBank) and 88 diseases
Chemical carcinogenesis - receptor activation
41 genes, 140 drugs (DrugBank) and 133 diseases
Cholinergic synapse
32 genes, 65 drugs (DrugBank) and 87 diseases
Circadian entrainment
22 genes, 42 drugs (DrugBank) and 62 diseases
Coronavirus disease
56 genes, 115 drugs (DrugBank) and 109 diseases
Cortisol synthesis and secretion
15 genes, 39 drugs (DrugBank) and 63 diseases
Cushing syndrome
23 genes, 56 drugs (DrugBank) and 71 diseases
Diabetic cardiomyopathy
25 genes, 48 drugs (DrugBank) and 80 diseases
Dilated cardiomyopathy
23 genes, 61 drugs (DrugBank) and 93 diseases
Dopaminergic synapse
33 genes, 105 drugs (DrugBank) and 105 diseases
GABAergic synapse
29 genes, 42 drugs (DrugBank) and 57 diseases
Gap junction
27 genes, 103 drugs (DrugBank) and 87 diseases
Glutamatergic synapse
23 genes, 32 drugs (DrugBank) and 82 diseases
GnRH secretion
27 genes, 49 drugs (DrugBank) and 62 diseases
GnRH signaling pathway
16 genes, 40 drugs (DrugBank) and 47 diseases
Growth hormone synthesis, secretion and action
23 genes, 49 drugs (DrugBank) and 97 diseases
Hormone signaling
64 genes, 217 drugs (DrugBank) and 150 diseases
Hypertrophic cardiomyopathy
26 genes, 57 drugs (DrugBank) and 97 diseases
Insulin secretion
16 genes, 51 drugs (DrugBank) and 61 diseases
Long-term potentiation
18 genes, 37 drugs (DrugBank) and 87 diseases
MAPK signaling pathway
70 genes, 101 drugs (DrugBank) and 117 diseases
Neuroactive ligand signaling
92 genes, 239 drugs (DrugBank) and 118 diseases
Neuroactive ligand-receptor interaction
156 genes, 371 drugs (DrugBank) and 171 diseases
Oxytocin signaling pathway
34 genes, 85 drugs (DrugBank) and 112 diseases
Pathways in cancer
116 genes, 235 drugs (DrugBank) and 150 diseases
Pathways of neurodegeneration - multiple diseases
64 genes, 143 drugs (DrugBank) and 141 diseases
Phospholipase D signaling pathway
24 genes, 60 drugs (DrugBank) and 84 diseases
Prion disease
41 genes, 77 drugs (DrugBank) and 121 diseases
Regulation of lipolysis in adipocytes
13 genes, 72 drugs (DrugBank) and 80 diseases
Renin secretion
28 genes, 90 drugs (DrugBank) and 108 diseases
Renin-angiotensin system
6 genes, 22 drugs (DrugBank) and 33 diseases
Retrograde endocannabinoid signaling
34 genes, 70 drugs (DrugBank) and 74 diseases
Salivary secretion
20 genes, 75 drugs (DrugBank) and 75 diseases
Serotonergic synapse
40 genes, 130 drugs (DrugBank) and 89 diseases
Taste transduction
29 genes, 93 drugs (DrugBank) and 78 diseases
Thermogenesis
17 genes, 31 drugs (DrugBank) and 89 diseases
Tight junction
13 genes, 38 drugs (DrugBank) and 54 diseases
Type II diabetes mellitus
15 genes, 44 drugs (DrugBank) and 100 diseases
Vascular smooth muscle contraction
32 genes, 95 drugs (DrugBank) and 74 diseases
